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ABSTRACT
OBJECTIVE
To investigate the associations between air pollution 
and mortality, focusing on associations below current 
European Union, United States, and World Health 
Organization standards and guidelines.
DESIGN
Pooled analysis of eight cohorts.
SETTING
Multicentre project Effects of Low-Level Air Pollution: A 
Study in Europe (ELAPSE) in six European countries.
PARTICIPANTS
325 367 adults from the general population recruited 
mostly in the 1990s or 2000s with detailed lifestyle 
data. Stratified Cox proportional hazard models 
were used to analyse the associations between air 
pollution and mortality. Western Europe-wide land 
use regression models were used to characterise 
residential air pollution concentrations of ambient fine 
particulate matter (PM2.5), nitrogen dioxide, ozone, 
and black carbon.
MAIN OUTCOME MEASURES
Deaths due to natural causes and cause specific 
mortality.
RESULTS
Of 325 367 adults followed-up for an average of 
19.5 years, 47 131 deaths were observed. Higher 
exposure to PM2.5, nitrogen dioxide, and black 
carbon was associated with significantly increased 
risk of almost all outcomes. An increase of 5 µg/m3 
in PM2.5 was associated with 13% (95% confidence 
interval 10.6% to 15.5%) increase in natural deaths; 
the corresponding figure for a 10 µg/m3 increase 
in nitrogen dioxide was 8.6% (7% to 10.2%). 
Associations with PM2.5, nitrogen dioxide, and black 
carbon remained significant at low concentrations. For 
participants with exposures below the US standard 
of 12 µg/m3 an increase of 5 µg/m3 in PM2.5 was 
associated with 29.6% (14% to 47.4%) increase in 
natural deaths.
CONCLUSIONS
Our study contributes to the evidence that outdoor 
air pollution is associated with mortality even at low 
pollution levels below the current European and North 
American standards and WHO guideline values. These 
findings are therefore an important contribution to the 
debate about revision of air quality limits, guidelines, 
and standards, and future assessments by the Global 
Burden of Disease.
Introduction
Epidemiological cohort studies have consistently 
found associations between long term exposure 
to outdoor air pollution and a range of morbidity 
and mortality endpoints. Concentrations of health 
relevant regulated pollutants, including fine particles 
and nitrogen dioxide, have decreased in the past 
decades in developed countries. Recent evaluations 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
In the framework of the update of the World Health Organization air quality 
guidelines, systematic reviews of studies of the effect of long term exposure to 
major outdoor air pollutants (fine particles, nitrogen dioxide, and ozone) have 
been done
Findings showed that long term exposure to ambient air pollution was 
significantly associated with natural and cause specific mortality, but 
associations at concentrations below current limit values were not well 
understood
WHAT THIS STUDY ADDS
Long term exposure to outdoor air pollution was positively associated with 
mortality even at levels well below the EU limit values, US Environmental 
Protection Agency national ambient air quality standards, and WHO air quality 
guidelines for fine particles and nitrogen dioxide
This new evidence supports reconsideration of existing guideline values and 
standards
The finding of associations at low levels of air pollution and mortality also 
supports policies to reduce air pollution below current legal limit values
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by the World Health Organization and the Global 
Burden of Disease study have suggested that health 
effects might persist at these lower concentrations.1-3 
However, there is uncertainty about the shape of the 
concentration-response function at the low end of the 
air pollution concentration distribution, related to the 
scarcity of observations at the lowest concentrations. 
Associations with mortality at low pollution levels in 
large populations were primarily investigated in a few 
North American studies, specifically the Canadian 
census cohort, the Canadian Community Health 
survey, the US Medicare cohort, and the US National 
Health Interview Survey study.4-10 All the studies 
found associations below the current annual average 
US standard of 12 µg/m3 and WHO guideline value 
of 10 µg/m3 for fine particles with an aerodynamic 
diameter of <2.5 µm (PM2.5), but only two studies were 
able to adjust for detailed individual lifestyle factors.7 9 
Most of the studies suggested a steeper concentration 
response function at the lowest levels, but the National 
Health Interview Survey study9 suggested little 
association below about 5 µg/m3. Most studies focused 
primarily on PM2.5, whereas increasing evidence shows 
that pollutants related to local combustion sources, 
including nitrogen dioxide and black carbon, might 
be relevant to health. Few studies have assessed the 
mortality effects of long term exposure to ozone.
Within the project Effects of Low-Level Air Pollution: 
A Study in Europe (ELAPSE) we assessed associations 
of low level air pollution concentrations with natural 
and cause specific mortality. Low level air pollution 
was defined as concentrations below current European 
Union limit values, US Environmental Protection 
Agency national ambient air quality standards, or 
the 2005 WHO air quality guidelines. We investigated 
PM2.5, nitrogen dioxide, ozone, and black carbon at 
a fine spatial resolution. To have sufficient statistical 
power to detect associations at low exposure levels, 
we pooled data from eight European cohorts with 
information on important individual risk factors, 
including smoking and body mass index.
Methods
Study population
The eight cohorts were selected from six European 
countries (see supplementary figure): Sweden 
(Stockholm county), Denmark (Copenhagen and 
Aarhus, and nationwide), France (nationwide), 
the Netherlands (four cities), Germany (Ruhr and 
Augsburg areas), and Austria (Vorarlberg region). 
All the cohorts, except the Danish cohort,11 were 
previously part of the European Study of Cohorts for 
Air Pollution Effects (ESCAPE).12 Not all ESCAPE 
cohorts were included, either because of relatively 
high annual air pollution concentrations or because 
the data could not be pooled. Several of the included 
cohorts (ie, from Sweden, Denmark, the Netherlands, 
and Augsburg, Germany) combined multiple original 
cohorts, termed subcohorts. All cohorts and subcohorts 
included general population samples and specific 
subgroups, such as Danish nurses (DNC cohort). 
Most cohorts were from large cities and surrounding 
regions. Supplementary appendix section 1 describes 
the cohorts in more detail. Recruitment of most of the 
cohorts was in the 1990s or 2000s (supplementary 
table S1).
To pool data, we used a common codebook to 
harmonise individual and area level covariates and 
outcome variables between cohorts. Information on 
covariates was only available at baseline.
Assessment of exposure to air pollution
We assessed air pollution concentrations at the 
baseline residential address of the study participants 
using land use regression models, described in detail 
elsewhere.13 Briefly, we estimated 2010 annual mean 
PM2.5, nitrogen dioxide, black carbon, and (warm 
season) ozone concentrations using the European 
Environmental Agency AirBase routine monitoring 
data (PM2.5, nitrogen dioxide, and ozone) and 
ESCAPE monitoring data (black carbon). Predictors 
were satellite derived and chemical transport model 
air pollutant estimates at 10×10 km, and fine scale 
land use and road traffic data. Western Europe-wide 
models were developed on a 100×100 m grid and 
were assigned to the participants using their geocoded 
residential address. The PM2.5, nitrogen dioxide, 
black carbon, and ozone models generally explained 
a large fraction of measured spatial variation of the 
annual average concentration: 72%, 59%, 54%, 
and 69%, respectively. In the ELAPSE paper on 
exposures13 we reported performance of the models by 
comparing with the external ESCAPE measurements 
by cohort (typically 20 sites for PM2.5 and 40 sites for 
nitrogen dioxide). The root means square error of this 
comparison was between 1.0 µg/m3 and 1.7 µg/m3 
for PM2.5, except for the French cohort, where the 
value was 3.3 µg/m3. For nitrogen dioxide, the root 
means square error was between 5 µg/m3 and 7 µg/m3, 
except for the nationwide French cohort (12 µg/m3). 
Differences were therefore modest, and some of the 
variability was probably related to the small number 
of sites in each ESCAPE area. To enable time varying 
exposure analysis, we extrapolated concentrations to 
every year of follow-up using the estimated annual 
concentrations from the Danish eulerian hemispheric 
model, which models monthly average concentrations 
across Europe at 26×26 km spatial resolution back to 
1990.14
Mortality data
Mortality was defined based on the underlying cause 
of death recorded on death certificates in mortality 
registries as ICD-9 and ICD-10 (international 
classification of diseases, ninth and 10th revisions, 
respectively) codes. We analysed mortality from natural 
causes (ICD-9: 001-779; ICD-10: A00-R99) and cause 
specific mortality for cardiovascular disease (ICD-9: 
400-440; ICD-10: I10-I70), ischaemic heart disease 
(ICD-9: 410-414; ICD-10: I20-I25), cerebrovascular 
disease (ICD-9: 430-438; ICD-10: I60-I69), respiratory 
disease (ICD-9: 460-519; ICD-10: J00-J99), chronic 
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obstructive pulmonary disease (ICD-9: 490-492, 494, 
496; ICD-10: J40-J44, J47), diabetes (ICD-9: 249-
250; ICD-10: E10-E14), and cardiometabolic diseases 
(cardiovascular disease or diabetes). The end of follow-
up for mortality was until 2011-15, depending on the 
cohort (supplementary table S1).
Statistical analysis
We analysed the associations between air pollution 
and mortality using Cox proportional hazards models 
stratified by sex and cohort or subcohort, with age 
as underlying timescale. Censoring occurred at the 
time of the event of interest, death from other causes, 
emigration, loss to follow-up for other reasons, or end 
of follow-up, whichever came first. Strata for cohorts 
or subcohorts were applied because of concerns about 
differences not fully accounted for by the available 
covariates and departures from the proportional 
hazard assumption.15
We specified three confounder models a priori, 
with an increasing level of adjustment for individual 
and area level variables. Model 1 included age (as 
the timescale), sex (strata), and year of enrolment. 
Model 2 further included smoking status, duration 
and intensity of smoking (linear and squared for 
intensity), body mass index, marital status, and 
employment status. Model 3 further expanded model 
2 with neighbourhood or municipal level mean income 
in 2001. We determined models 2 and 3 based on the 
ESCAPE confounder models12 and detailed sensitivity 
analyses, in which we balanced the need to adjust for 
a comprehensive set of covariates and the availability 
of these covariates for most participants. Model 3 was 
considered the main model.
In addition to the main linear model, we assessed 
the shape of the concentration-response association 
between air pollution and mortality using both natural 
cubic splines with three degrees of freedom and the 
shape constrained health impact function (SCHIF). 
The SCHIF method assesses several different shapes of 
the association as variations of sigmoidal functions to 
produce biologically plausible concentration-response 
functions, resulting in an “optimal” and “ensemble” 
of all fitted shapes.16 The SCHIF shapes are smoother 
and less affected by sparse data than natural cubic 
splines. We also performed analyses with exposure 
grouped into quarters for natural, cardiovascular, and 
respiratory mortality.
Furthermore, we performed several sensitivity 
analyses. The associations with linear models were 
analysed in subsets of concentrations by excluding 
observations above specific values. We evaluated 
cut-offs including current EU limit values (25 μg/m3 
PM2.5, 40 μg/m
3 nitrogen dioxide), US Environmental 
Protection Agency national ambient air quality 
standards (12 μg/m3 PM2.5), and WHO air quality 
guidelines (10 μg/m3 PM2.5, 40 μg/m
3 nitrogen 
dioxide).
To disentangle the effect of individual pollutants, 
we specified linear models of two pollutants for all 
combinations of the four pollutants. We did not specify 
three pollutant models because of the high correlations 
between pollutants within cohorts.
As some potential confounders were not available 
in all cohorts, we tested the sensitivity of our findings 
by adjusting for additional variables such as education 
and performing a leave one out cohort analysis.
We assessed effect modification by covariates 
available in all cohorts and subcohorts. Because we 
stratified for sex in our main model, we changed the 
formulation to include sex as a covariate in the model. 
We then added pollution as an interaction variable, as 
with the other effect modifiers (restoring strata for sex 
as in the main model).
We assessed the sensitivity of our findings to 
using the exposure in 2010 by analysing the back 
extrapolated concentrations at each cohort’s baseline 
year and by time varying exposures from enrolment to 
end of follow-up. Residential history was incorporated 
in the time varying exposure analyses. In the time 
varying analysis, one and five year period strata were 
used in the Cox models to account for time trends in 
mortality and air pollution.
Because air pollution and noise might be correlated, 
we conducted additional adjustment for road traffic 
noise. Details on assessment of noise exposure are 
provided elsewhere.17
We used multiple imputation by chained equations18 
to fill in missing values for confounders, provided that 
a cohort had information for a variable for part of the 
cohort (supplementary appendix, section 2).
Analyses were performed in R (version 3.4.0).19 
Supplementary appendix, section 3, lists the packages 
used in the analyses.
Patient and public involvement
As we used existing cohorts recruited more than a 
decade ago, we could not involve patients in the design 
of the study and the paper. We will prepare press 
releases and share the findings through publications, 
talks, and social media, addressing larger audiences 
that include members of the public, patients, health 
professionals, and stakeholders.
Results
Population and exposure characteristics
Cohorts differed in all characteristics, supporting the 
analysis using strata for cohorts and subcohorts (table 
1 and supplementary tables S1 and S2). Observations 
were pooled from 381 036 participants. Owing to 
missing covariate data, 325 367 participants were 
included in the main analysis. The Austrian VHM&PP 
cohort contributed 45% of participants. Nearly all 
participants were exposed to PM2.5 levels below the EU 
limit value (25 µg/m3), more than 50 000 were exposed 
to levels below the US Environmental Protection 
Agency national ambient air quality standards (12 
µg/m3), and more than 25 000 were exposed to levels 
below the WHO air quality guidelines (10 µg/m3). More 
than 310 000 participants were exposed to nitrogen 
dioxide levels below the EU limit values and WHO air 
quality guidelines (40 µg/m3).
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Large north to south upward gradients in exposure to 
air pollution were observed between cohorts (figure 1 
and table S3). Variations in black carbon and nitrogen 
dioxide within cohorts were especially substantial. 
Contrast for ozone was low within cohorts.
PM2.5 was moderately to highly correlated with black 
carbon and nitrogen dioxide within most cohorts 
(supplementary table S4). Black carbon and nitrogen 
dioxide were highly correlated in most cohorts. Ozone 
was negatively correlated with PM2.5 and especially 
nitrogen dioxide and black carbon in all cohorts, 
with a particularly high negative correlation in the 
large Austrian cohort. The within cohort correlation 
is important since strata were used for cohorts and 
subcohorts in the epidemiological analysis.
Associations with mortality
Main analysis
Associations between PM2.5, nitrogen dioxide, and 
black carbon and almost all outcomes were significantly 
positive in linear analysis (table 2). Effect estimates 
for PM2.5 were similar for deaths from natural causes 
and cardiovascular disease and lower for deaths from 
respiratory disease but similar for nitrogen dioxide and 
black carbon. The highest hazard ratios were found for 
deaths due to diabetes, with wider confidence intervals 
owing to a small number of deaths. Associations were 
significantly negative for ozone and all outcomes, 
related to the negative correlation between ozone and 
the other pollutants (participants with high exposure 
to ozone had low exposures to PM2.5, black carbon, and 
nitrogen dioxide).
Hazard ratios (95% confidence intervals) from the 
main linear model (model 3) presented for the following 
increments: PM2.5 5 µg/m
3, nitrogen dioxide 10 µg/m3 
black carbon 0.5×10−5/m, and ozone 10 µg/m3. 
These increments were chosen to reflect contrast in 
exposure for the pollutants, in accordance with the 
ESCAPE study. Main model adjusted for cohort or 
subcohort, age, sex, year of baseline visit, smoking 
status (current, former, never), smoking duration 
(years), smoking intensity (cigarettes/day, both linear 
and quadratic terms), body mass index ( <18.5, 18.5-
24.9, 25-29.9, >30), marital status (single, married 
or cohabiting, divorced or separated, widowed), 
employment status (yes or no), and 2001 small area 
level mean income. Natural mortality: 001-779 (ICD-
9) and A00–R99 (ICD-10); cardiovascular disease 
mortality: 400-440 (ICD-9) and I10-I70 (ICD-10); 
ischaemic heart disease mortality: 410-414 (ICD-9) and 
I20-I25 (ICD-10); cerebrovascular disease mortality: 
430-438 (ICD-9) and I60-I69 (ICD-10); respiratory 
mortality: 460-519 (ICD-9) and J00-J99 (ICD-10); 
chronic obstructive pulmonary disease mortality: 
490-492, 494, 496 (ICD-9) and J40-J44, J47 (ICD-10); 
diabetes mortality: 249-250 (ICD-9) and E10-E14 (ICD-
10); and cardiometabolic disease mortality: defined 
as mortality due to either cardiovascular disease or 
diabetes.
Figure 2 and supplementary figure S1 show the 
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dioxide, and deaths from natural causes using natural 
splines. Associations for natural deaths were observed 
over the full range of exposures. Associations tended to 
be steeper at low concentrations, levelling off at high 
concentrations. At the extremes of the distribution, 
patterns occurred that were difficult to interpret, 
related to large uncertainty about the shape of the 
curve as indicated by wide confidence intervals. For 
the association between PM2.5 and deaths due to 
respiratory disease and chronic obstructive pulmonary 
disease, the pattern was difficult to interpret as a 
decreasing trend occurred associated with relatively 
frequently occurring exposures. Concentration-
response functions for cause specific mortality were in 
general similar to those for natural deaths, indicating 
mostly supralinear curves, with associations remaining 
at low levels (figure 2 and supplementary figures S2-
S6). The analyses of exposure grouped into quarters 
confirmed the linear to supralinear curves in the 
splines, except for PM2.5 and deaths due to respiratory 
disease (supplementary table S5).
The SCHIF shapes were generally in agreement 
with the shapes of the natural splines, indicating that 
evidence still exists for an association at low levels 
and the positive associations between pollution and 
natural and cause specific mortality are generally 
steeper at the low end of the distribution for PM2.5, 
nitrogen dioxide, and black carbon (supplementary 
figures S7-S12). The SCHIF shapes for nitrogen dioxide 
and deaths due to respiratory disease and chronic 
obstructive pulmonary disease suggest a flatter slope 
at low than at high concentrations.
Sensitivity analyses
Table 3 shows the hazards ratios for natural deaths 
observed in subsets of successively lower air pollution 
concentrations. Associations remained positive 
and statistically significant for PM2.5 even when all 
observations higher than 12 µg/m3 were removed from 
the analysis. The hazard ratios for participants with 
exposures below 10 µg/m3 was similar to those for all 
observations but with wider confidence intervals. For 
nitrogen dioxide, associations remained significantly 
positive below 20 µg/m3, well below current standards. 
Similar patterns were found for cause specific mortality 
(table 3), with wider confidence intervals associated 
with smaller number of deaths.
Associations for PM2.5 and nitrogen dioxide were 
attenuated but remained significant after adjustment 













































































































































































































Fig 1 | Annual average exposure at participant (n=325 367) addresses. In boxes, the boundary closest to zero indicates 25th centile and furthest 
from zero indicates 75th centile. Lines in boxes represent the median and whiskers are 5th and 95th centiles. Dashed lines for fine particulate 
matter (PM2.5) indicate World Health Organization air quality guidelines (10 µg/m
3), US Environmental Protection Agency national ambient air quality 
standards (12 µg/m3), and EU limit value (25 µg/m3). Dashed lines for nitrogen dioxide indicate WHO air quality guidelines (40 µg/m3) and WHO 
health risks of air pollution in Europe (HRAPIE) health impact quantification threshold (20 µg/m3). Cohorts were ordered from north (top) to south 
(bottom). CEANS cohorts are from Stockholm county, Sweden, DCH from Copenhagen and Aarhus, Denmark, DNC from Denmark nationwide, EPIC-NL 
from four cities in the Netherlands, HNR from the Ruhr area, Germany, E3N from France nationwide, KORA from the Augsburg area, Germany, and 
VHM&PP from the Vorarlberg region, Austria
 on 15 O













J: first published as 10.1136/bm







6 doi: 10.1136/bmj.n1904 | BMJ 2021;374:n1904 | the bmj
carbon in models of two pollutants for deaths 
due to natural causes and cardiovascular disease 
(supplementary tables S6 and S7). For deaths due to 
respiratory disease, only associations for nitrogen 
dioxide were robust to adjustment for other pollutants 
(supplementary table S8). The negative association 
with ozone attenuated towards unity but remained 
statistically significant.
Air pollution concentrations have decreased 
substantially in Europe since the 1990s (supplementary 
figure S13). Exposures to PM2.5 especially were 
substantially higher at baseline than in 2010 
(supplementary figure S14); exposures to nitrogen 
dioxide and black carbon were moderately higher at 
baseline (supplementary appendix, section 7). When 
exposure to baseline air pollution was used instead of 
the 2010 exposure, hazard ratios especially for PM2.5 
were found to be smaller than in the main analysis, 
although still statistically significant (supplementary 
table S9). Hazard ratios in the time varying exposure 
analyses were similar to those of the analysis using 
the 2010 exposure (supplementary table S10). As 
time trends were different across Europe, different 
trends were specified for each cohort. Natural spline 
analysis conducted in time varying exposure analyses 
supported the findings that mortality associations 
remained at low levels and were not associated with 
the use of the 2010 exposure as an exposure estimate 
(supplementary figure S15).
Further adjustment for education, diet, and 
occupational status did not affect effect estimates 
obtained with the main model (supplementary table 
S11). Effect estimates were not (PM2.5) or were mildly 
(nitrogen dioxide, black carbon) affected by exclusion 
of specific cohorts, such as the large Austrian VHM&PP 
cohort (supplementary figure S16). The hazard ratio for 
ozone was substantially closer to unity when excluding 
the Austrian cohort. Effect estimates for deaths due to 
natural causes and cardiovascular disease were only 
mildly attenuated by additional adjustment for road 
traffic noise (supplementary table S12). The negative 
ozone associations were attenuated to unity in models 
of two pollutants (adjusting the ozone association for 
one of the other pollutants, one at a time) without the 
Austrian cohort and with additional adjustment for 
road traffic noise (supplementary tables S13 and S14). 
Hazard ratios were unchanged after using multiple 
imputation to estimate missing covariate data in the 
full study population (supplementary table S15).
Indications of effect modification were found for 
sex (higher hazard ratio in men; supplementary figure 
S17), smoking status for PM2.5 (higher hazard ratio 
in current smokers, but also significant associations 
in never smokers), age for nitrogen dioxide (higher 
hazard ratio in those aged <65 years). Effect estimates 
remained significant in all strata of participants except 
those with a very low body mass index (<18.5).
Discussion
By performing targeted analyses within a large 
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individual lifestyle covariates, we found significant 
positive associations between residential exposure 
to PM2.5, nitrogen dioxide, and black carbon and 
deaths due to natural causes, cardiovascular disease, 
and respiratory disease. For these pollutants, we 
generally observed associations that were stronger at 
low exposure levels. Subset analyses documented that 
these associations remained even at levels for PM2.5 
and nitrogen dioxide below current EU limit values, US 
Environmental Protection Agency national ambient air 
quality standards, and WHO air quality guidelines.
Comparison with other studies
The estimated hazard ratio for mortality associated 
with PM2.5 in our study is larger than the estimate 
from the ESCAPE study,12 estimates from recent North 
American administrative cohorts5 6 8 20 and a recent 
Danish study,21 and estimates from meta-analyses22-24 
(supplementary table S16), but almost identical to 
the results of the Canadian community health survey 
study.7 The recent WHO systematic review documented 
heterogeneity in PM2.5 effect estimates between studies, 
attributed to study location, level, and composition of 
particulate matter and to methodological differences.24 
In our cohort, similarly to the Canadian community 
health survey, individual lifestyle data were available, 
which are missing in large administrative cohorts. 
The sensitivity analysis using PM2.5 estimates at 
baseline year of exposure showed clearly smaller 
effect estimates. These estimates are more in line 
with effect estimates reported in a recent systematic 
review, suggesting that the effect estimate using the 
2010 concentrations as exposure variable might be 
overestimating the true effect estimate. Effect estimates 
from time varying exposure analyses were similar to 
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Fig 2 | Natural cubic splines (three degrees of freedom) for associations between exposure to air pollution and deaths due to natural causes, 
cardiovascular disease, and respiratory disease. Purple shaded areas represent 95% confidence intervals. Histogram of exposure added to illustrate 
sparse data regions. Dashed lines for fine particulate matter (PM2.5) indicate World Health Organization air quality guidelines (10 µg/m
3), the 
primary US Environmental Protection Agency standard (12 µg/m3), and the secondary US EPA standard (15 µg/m3), all as annual averages. For 
nitrogen dioxide the red lines indicate the WHO suggested limit for burden of disease quantification (20 µg/m3) and EU limit value and WHO air 
quality guidelines (40 µg/m3). Patterns at the extremes are difficult to interpret owing to wide confidence intervals
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nitrogen dioxide were also higher than those in recent 
meta-analyses (supplementary table S12).
Our study contributes to the evidence that outdoor 
air pollution is associated with mortality even at levels 
below the current European and North American 
standards and WHO guideline values. When we applied 
two methods allowing non-linear concentration-
response functions and linear analyses in subsets of 
exposure, we found no indication of a level below which 
no association was found. The finding of associations 
at low levels is consistent with that of several other 
recent cohort studies.4-8 25-29 The steeper slope of the 
PM2.5 mortality association at low levels is consistent 
with previous North American studies.4-8 In some other 
cohort studies, the shape of the PM2.5 function was 
sublinear30 31 or linear.25-27 In a comprehensive meta-
analysis that combined evidence from a large number 
of cohorts, a supralinear association was observed 
for PM2.5.
32 Considerably less evidence is available 
about associations between low level nitrogen dioxide 
and mortality. In two large administrative cohorts 
in Canada and the Netherlands, associations with 
nitrogen dioxide were also found well below the WHO 
guideline value.5 33 Our study found associations at 
levels twofold lower than the current WHO guideline 
values for long term exposure to nitrogen dioxide.
Models of two pollutants showed that both PM2.5 
and nitrogen dioxide were associated with mortality. 
Whereas PM2.5 primarily reflects pollution transported 
over large distances, nitrogen dioxide reflects local 
fossil fuel combustion sources, especially motorised 
traffic.
Our results for ozone did not confirm previously 
reported positive associations with mortality.34 This 
might be related to the very small range of ozone 
exposure within our study, rendering our study less 
informative for assessing health effects of ambient 
ozone. The negative associations we found in single 
pollutant models might reflect the high negative 
correlation with especially nitrogen dioxide and black 
carbon. Ozone and nitrogen dioxide are negatively 
correlated because when ozone is close to combustion 
sources (eg, major roads), it reacts with nitric oxide 
emitted from the combustion source to form oxygen 
and nitrogen dioxide. Ozone therefore tends to be low 
near roadways, whereas black carbon emitted by traffic 
is high. Nitrogen dioxide is in part directly emitted 
from traffic and in part formed by the atmospheric 
reactions, so it is also high near roadways. In models 
of two pollutants and models adjusting for noise, the 
negative associations with ozone were attenuated to 
unity, especially when excluding the large Austrian 
cohort and adjusting for nitrogen dioxide and noise 
together. The very high negative correlation between 
ozone and nitrogen dioxide in the Austrian cohort 
renders models of two pollutants difficult to interpret.
Table 3 | Subset analysis of risk of death associated with exposure to air pollution
Pollutant by subset No
Mortality hazard ratio (95% CI)
Natural deaths Cardiovascular disease Respiratory disease
PM2.5
Full dataset 325 367 1.130 (1.106 to 1.155) 1.135 (1.095 to 1.176) 1.054 (0.961 to 1.156)
Pollution level (µg/m3):
 <25 325 339 1.131 (1.107 to 1.156) 1.135 (1.096 to 1.176) 1.050 (0.957 to 1.152)
 <20 316 540 1.138 (1.113 to 1.164) 1.141 (1.101 to 1.183) 1.071 (0.975 to 1.177)
 <15 151 250 1.257 (1.193 to 1.324) 1.276 (1.167 to 1.397) 1.322 (1.075 to 1.625)
 <12 52 528 1.296 (1.140 to 1.474) 1.238 (0.999 to 1.535) 1.417 (0.849 to 2.365)
 <10 25 422 1.146 (0.931 to 1.410) 0.863 (0.618 to 1.205) 1.489 (0.622 to 3.564)
Nitrogen dioxide
Full dataset 325 367 1.086 (1.070 to 1.102) 1.089 (1.060 to 1.120) 1.101 (1.038 to 1.168)
Pollution level (µg/m3):
 <40 310 643 1.101 (1.083 to 1.119) 1.104 (1.071 to 1.137) 1.099 (1.030 to 1.173)
 <30 247 039 1.114 (1.088 to 1.140) 1.117 (1.074 to 1.161) 1.049 (0.953 to 1.154)
 <20 88 510 1.099 (1.033 to 1.170) 1.171 (1.052 to 1.303) 1.044 (0.809 to 1.347)
Black carbon
Full dataset 325 367 1.081 (1.065 to 1.098) 1.085 (1.055 to 1.116) 1.084 (1.020 to 1.151)
Pollution level (×10−5/m):
 <3 324 757 1.084 (1.067 to 1.101) 1.087 (1.056 to 1.119) 1.085 (1.021 to 1.154)
 <2.5 320 632 1.091 (1.074 to 1.109) 1.090 (1.058 to 1.123) 1.100 (1.034 to 1.171)
 <2 296 371 1.107 (1.087 to 1.128) 1.107 (1.070 to 1.145) 1.119 (1.044 to 1.200)
 <1.5 142 032 1.125 (1.086 to 1.165) 1.150 (1.072 to 1.234) 1.127 (0.990 to 1.284)
 <1 35 406 1.041 (0.942 to 1.150) 0.895 (0.738 to 1.086) 1.186 (0.798 to 1.763)
Ozone
Full dataset 325 367 0.896 (0.878 to 0.914) 0.887 (0.854 to 0.922) 0.890 (0.821 to 0.966)
Pollution level (µg/m3):
 <120 325 367 0.896 (0.878 to 0.914) 0.887 (0.854 to 0.922) 0.890 (0.821 to 0.966)
 <100 320 522 0.891 (0.872 to 0.910) 0.880 (0.846 to 0.915) 0.891 (0.820 to 0.969)
 <80 98 840 0.979 (0.940 to 1.018) 1.021 (0.938 to 1.111) 0.890 (0.772 to 1.025)
PM2.5=fine particulate matter with an aerodynamic diameter of <2.5 µm. 
Hazard ratios (95% confidence intervals) from the main linear model (model 3) presented for the following increments: PM2.5 5 µg/m
3, nitrogen 
dioxide 10 µg/m3, black carbon 0.5×10−5/m, and ozone 10 µg/m3. These increments were chosen to reflect contrast in exposure for the pollutants, in 
accordance with the ESCAPE study. Main model adjusted for cohort or subcohort, age, sex, year of baseline visit, smoking status (current, former, never), 
smoking duration (years), smoking intensity (cigarettes/day, both linear and quadratic terms), body mass index ( <18.5, 18.5-24.9, 25-29.9, >30), marital 
status (single, married or cohabiting, divorced or separated, widowed), employment status (yes or no), and 2001 small area level mean income.
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Strengths and limitations of this study
An important strength of ELAPSE is the pooling of 
data from multiple European cohorts with detailed 
information on individual covariates (eg, smoking, 
body mass index), which allowed for more statistical 
power and analysis of the shapes of concentration-
response functions. A part of the pooling process 
was an extensive, highly standardised procedure 
of harmonisation of individual and small area level 
variables between all cohorts. Another strength of the 
study is that we used state-of-the-art models to enable 
a uniform assessment of exposure to air pollution 
at a fine, 100×100 m scale for all four pollutants. 
Compared with the ESCAPE study,12 we had longer 
follow-up time.
A limitation of our study is the use of the 2010 
exposure in our main analyses. The rationale for 
using the 2010 exposure was that in earlier years we 
did not have enough monitoring stations in Europe 
to develop the fine spatial scale models for PM2.5. The 
2010 exposure represents exposure towards the end of 
follow-up for most cohorts. Given the downward trends 
in air pollution, a concern is that 2010 exposure might 
not correctly reflect the long term exposure leading 
to increased mortality. Previous studies, however, 
have documented that spatial contrasts in nitrogen 
dioxide and black carbon remain constant for at least 
a decade,35-38 supporting the use of 2010 exposures in 
the analysis. Our sensitivity analyses with time varying 
exposure resulted in similar findings to the main 
model.
For PM2.5 mainly, northern European cohorts 
contributed to the effect estimates in the lowest 
exposure range and we therefore could not distinguish 
between the characteristics of the particulate matter 
mixture or the population characteristics affecting the 
steeper slope at low levels. More overlap was found 
in exposure to nitrogen dioxide and black carbon 
between cohorts and we observed steeper slopes at low 
levels as well.
The difficulty in interpreting the non-linear function 
observed for deaths due to respiratory disease could 
be related to competing risks of death that we did not 
account for in our study.
Bias from exposure misclassification and residual 
confounding cannot be excluded. As exposure 
status was determined fully independently from the 
outcome, misclassification is likely non-differential 
and thus biased towards the null. We adjusted for 
several commonly used potential confounders, and 
adjustment for socioeconomic status might reduce 
confounding by other risk factors.
The coding for the causes of the death in the current 
study were brought in line with the previous ESCAPE 
analyses. These differ slightly from the ones used by 
the Global Burden of Disease. Owing to that, we do not 
expect major differences.
Conclusions
Our study contributes to the evidence that outdoor air 
pollution is associated with mortality even at levels 
below the current European and North American 
standards and WHO guideline values. These findings 
are therefore an important contribution to the debate 
about revision of air quality limits, guidelines and 
standards, and future assessments by the Global 
Burden of Disease.
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